首页 >
法规速递
-
Document: Start of procedure: Extension of marketing authorisation (22 May 2026 - 25 June 2026)-2026/7/6
2026-07-07查看详情 > -
Document: Product Management Service (PMS) – Frequently Asked Questions (FAQs)-2026/8/12
2026-08-13查看详情 > -
M11 Technical Specification: Clinical Electronic Structured Harmonised Protocol (Draft)-2022/12/21
2022-12-22查看详情 > -
国家药品监督管理局批准利司扑兰口服溶液用散扩展儿童适用人群-2023/6/30
2023-06-30查看详情 > -
国家药监局药审中心关于发布《人纤维蛋白原临床试验技术指导原则（修订版）》的通告（2023年第61号）-2023/12/29
2024-01-19查看详情 > -
Page: CHMP opinions on consultation procedures-2025/1/24
2025-02-05查看详情 > -
Document: Procedural advice on CHMP/CAT/PRAC Rapporteur/Co-Rapporteur appointment principles, objective criteria and methodology in accordance with Article 62 (1) of Regulation (EC) No 726/2004-2025/2/28
2025-03-03查看详情 > -
国家药监局综合司关于公开征求《医疗器械分类规则（修订草案征求意见稿）》意见的函-2025/4/7
2025-04-08查看详情 > -
2025年05月16日中药品种保护受理公示-2025/5/16
2025-05-19查看详情 > -
Document: List of medicinal products under additional monitoring-2025/6/25
2025-06-26查看详情 >
